PROVETOP

Biotinylated Human B7-H3 (2Ig)/CD276 Protein

Catalog No: B7H3-HB003

Species
Human
Expression System
HEK293
Tag
an hFc (IgG1), Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Human B7-H3/CD276 Protein is expressed in HEK293 cells with an hFc (IgG1) tag and Avi tag at the C-terminus. It contains amino acid residues Leu29-Pro245 (UniProt accession: Q5ZPR3-2).

Product Details

Molecular Aliases
B7H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3; CD276
Protein Length
Leu29-Pro245
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 51.06 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
B7H3-HB003 Bis-Tris-PAGE-white result

Biotinylated Human B7-H3 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
B7H3-HB003 SEC-HPLC result

The purity of Biotinylated Human B7-H3 is greater than 95% as determined by SEC-HPLC.

ELISA
B7H3-HB003 ELISA result

Immobilized Anti-B7-H3 Antibody, hFc Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human B7-H3, hFc Tag with the EC50 of 25.3ng/ml determined by ELISA (QC Test).

BLI
B7H3-HB003 BLI result

Loaded Biotinylated Human B7-H3, hFc-Avi tag on Streptavidin-Biosensor can bind Anti-B7-H3 Ab., hFc Tag with an affinity constant of 0.30 nM as determined in BLI assay.

Background

B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.

References

  1. Fodstad O, Tekle C, Chen Y W. The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion[J]. Current Cancer Drug Targets, 2008, 8(5)
  2. Du H, Hirabayashi K, Ahn S, et al. Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells[J]. Cancer Cell, 2019, 35(2). Note: HPLC results always come from liquid protein, due to absorption peak interference of trehalose in lyophilized powder.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support